Shimomura, H.; Tokunaga, S.; Terasaki, E.; Taniguchi, N.; Taniguchi, Y.; Yoshitake, S.; Terakita, Y.; Inoue, K.; Okuda, M.; Kato, T.;
et al. Cyproheptadine Treatment in Children and Adolescents with Migraine: A Retrospective Study in Japan. Neurol. Int. 2024, 16, 1308-1317.
https://doi.org/10.3390/neurolint16060099
AMA Style
Shimomura H, Tokunaga S, Terasaki E, Taniguchi N, Taniguchi Y, Yoshitake S, Terakita Y, Inoue K, Okuda M, Kato T,
et al. Cyproheptadine Treatment in Children and Adolescents with Migraine: A Retrospective Study in Japan. Neurology International. 2024; 16(6):1308-1317.
https://doi.org/10.3390/neurolint16060099
Chicago/Turabian Style
Shimomura, Hideki, Sachi Tokunaga, Eisuke Terasaki, Naoko Taniguchi, Yohei Taniguchi, Saeka Yoshitake, Yuki Terakita, Kenji Inoue, Masumi Okuda, Takeo Kato,
and et al. 2024. "Cyproheptadine Treatment in Children and Adolescents with Migraine: A Retrospective Study in Japan" Neurology International 16, no. 6: 1308-1317.
https://doi.org/10.3390/neurolint16060099
APA Style
Shimomura, H., Tokunaga, S., Terasaki, E., Taniguchi, N., Taniguchi, Y., Yoshitake, S., Terakita, Y., Inoue, K., Okuda, M., Kato, T., & Takeshima, Y.
(2024). Cyproheptadine Treatment in Children and Adolescents with Migraine: A Retrospective Study in Japan. Neurology International, 16(6), 1308-1317.
https://doi.org/10.3390/neurolint16060099
